1. Home
  2. JAGX vs GRNQ Comparison

JAGX vs GRNQ Comparison

Compare JAGX & GRNQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • JAGX
  • GRNQ
  • Stock Information
  • Founded
  • JAGX 2013
  • GRNQ 2013
  • Country
  • JAGX United States
  • GRNQ Malaysia
  • Employees
  • JAGX N/A
  • GRNQ N/A
  • Industry
  • JAGX Biotechnology: Pharmaceutical Preparations
  • GRNQ EDP Services
  • Sector
  • JAGX Health Care
  • GRNQ Technology
  • Exchange
  • JAGX Nasdaq
  • GRNQ Nasdaq
  • Market Cap
  • JAGX 7.4M
  • GRNQ 6.8M
  • IPO Year
  • JAGX N/A
  • GRNQ 2018
  • Fundamental
  • Price
  • JAGX $5.88
  • GRNQ $1.35
  • Analyst Decision
  • JAGX
  • GRNQ
  • Analyst Count
  • JAGX 0
  • GRNQ 0
  • Target Price
  • JAGX N/A
  • GRNQ N/A
  • AVG Volume (30 Days)
  • JAGX 247.5K
  • GRNQ 50.7K
  • Earning Date
  • JAGX 05-15-2025
  • GRNQ 05-14-2025
  • Dividend Yield
  • JAGX N/A
  • GRNQ N/A
  • EPS Growth
  • JAGX N/A
  • GRNQ N/A
  • EPS
  • JAGX N/A
  • GRNQ N/A
  • Revenue
  • JAGX $11,689,000.00
  • GRNQ $3,190,761.00
  • Revenue This Year
  • JAGX $22.41
  • GRNQ N/A
  • Revenue Next Year
  • JAGX $30.00
  • GRNQ N/A
  • P/E Ratio
  • JAGX N/A
  • GRNQ N/A
  • Revenue Growth
  • JAGX 19.75
  • GRNQ N/A
  • 52 Week Low
  • JAGX $4.02
  • GRNQ $0.80
  • 52 Week High
  • JAGX $502.50
  • GRNQ $2.24
  • Technical
  • Relative Strength Index (RSI)
  • JAGX 37.09
  • GRNQ 82.76
  • Support Level
  • JAGX $5.30
  • GRNQ $0.88
  • Resistance Level
  • JAGX $13.20
  • GRNQ $0.97
  • Average True Range (ATR)
  • JAGX 1.49
  • GRNQ 0.12
  • MACD
  • JAGX -0.57
  • GRNQ 0.03
  • Stochastic Oscillator
  • JAGX 7.30
  • GRNQ 85.71

About JAGX Jaguar Health Inc.

Jaguar Health Inc is a commercial-stage pharmaceuticals company focused on developing novel, plant-based, non-opioid, and sustainably derived prescription medicines for people and animals with GI distress, specifically chronic, debilitating diarrhea. Its product Mytesi is a novel, first-in-class anti-secretory agent which has a basic normalizing effect locally on the gut, and this mechanism of action has the potential to benefit multiple disorders. It has two reportable segments namely human health and animal health. The company generates the majority of its revenue from the Human Health segment.

About GRNQ Greenpro Capital Corp.

Greenpro Capital Corp operates and provides business solution services to small and medium-sized businesses located in Southeast Asia and East Asia, with a focus on Hong Kong, China and Malaysia, and in Thailand and Taiwan. Its range of services includes cross-border business solutions, record management services, and accounting outsourcing services. Cross-border business services include other services, tax planning, trust and wealth management. Its segments include Service business engaged in the provision of corporate advisory and business solution services; Real estate business segment engaged in trading or leasing of commercial real estate properties in Hong Kong and Malaysia; and Digital business segment engaged in provision of digital platform and trading of digital assets.

Share on Social Networks: